Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 31

Trial Status

Completed3
Recruiting2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT07301320Phase 2Recruiting
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Mycobacterium Abscessus Infection
PrincipalinvestigatorStart date: 2026-03-30
NCT05730283Phase 2Recruiting
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Ototoxicity, Drug-Induced
PrincipalinvestigatorStart date: 2025-06-02
NCT03672630Phase 2/3Completed
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Mycobacterium Avium ComplexNontuberculous Mycobacterium Infection
PrincipalinvestigatorStart date: 2019-02-22
NCT03038178Phase 2Completed
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
Mycobacteria, AtypicalMycobacterium Infections, Nontuberculous
PrincipalinvestigatorStart date: 2016-10-01

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Emily Henkle, PhD, MPH

Oregon Health and Science University

Moderately Similar
2 trials

Shared therapeutic areas:

BronchiectasisMycobacterium avium ComplexMycobacterium Infections, Nontuberculous

Worked with same sponsors:

Columbia UniversityCOPD Foundation+28 more
Collaborated on 2 trials
Similarity Score38%

Edwin Rubel, PhD

Oricula Therapeutics

Related
1 trials

Shared therapeutic areas:

Drug-Induced Ototoxicity

Worked with same sponsors:

Johns Hopkins UniversityKevin Winthrop+10 more
Collaborated on 1 trial
Similarity Score14%

Gina Eagle, MD

Insmed Incorporated

Related
8 trials

Shared therapeutic areas:

BronchiectasisMycobacterium Infections, Nontuberculous

Worked with same sponsors:

Insmed Incorporated
Similarity Score10%

Roberto Benzo, MD

Mayo Clinic

Related
6 trials

Shared therapeutic areas:

Bronchiectasis

Worked with same sponsors:

Mayo Clinic
Similarity Score5%

Jae-Joon Yim, MD

Seoul National University Hospital

Related
10 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score5%

Ada C Gastaldi, PhD

Ribeirão Preto Medicine School - University of São Paulo

Related
4 trials

Shared therapeutic areas:

Bronchiectasis
Similarity Score5%

Ahmad M. shaddad, MD

Assiut University

Related
6 trials

Shared therapeutic areas:

Bronchiectasis
Similarity Score5%

Ahmad M Shaddad, MD

Assiut University

Related
3 trials

Shared therapeutic areas:

Bronchiectasis
Similarity Score5%

John W Wilson, MBBS, PhD

The Alfred

Related
3 trials

Shared therapeutic areas:

Bronchiectasis
Similarity Score5%

rongchang chen, MD

The First Affiliated Hospital of Guangzhou Medical University

Related
6 trials

Shared therapeutic areas:

Bronchiectasis
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT07301320Phase 2PrincipalInvestigator

Epetraborole in Patients With Mycobacterium Abscessus Lung Disease

Mycobacterium Abscessus Infection
Recruiting
NCT05730283Phase 2PrincipalInvestigator

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Ototoxicity, Drug-Induced
Recruiting
NCT03672630Phase 2/3PrincipalInvestigator

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Mycobacterium Avium ComplexNontuberculous Mycobacterium Infection
Completed
NCT02714283PrincipalInvestigator

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

Bronchiectasis
Completed
NCT03038178Phase 2PrincipalInvestigator

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Mycobacteria, AtypicalMycobacterium Infections, Nontuberculous
Completed

All 5 trials loaded